Hima Bindu Gottam (Bindu) brings over 14 years of experience in pharmaceutical product and process development, lifecycle management, scale-up, technology transfer, manufacturing, quality management, and regulatory compliance. Her expertise spans pre-formulation and formulation sciences, analytical methods, and regulatory strategy, contributing to more than 20 FDA approvals across a wide range of complex dosage forms—including tablets, capsules, oral solutions, suspensions, topicals, transdermals, and sterile products.

Prior to joining UI Pharmaceuticals, Bindu spent over 11 years at three biopharmaceutical companies, where she played a key role in the development of multiple ANDA and NDA products. In her most recent role at Tolmar in northern Colorado, she worked extensively on complex sterile dosage forms, including long-acting injectable products using biodegradable polymers, drug-device combination products, and lyophilized injections.

At UI Pharmaceuticals, Bindu serves as a subject matter expert for all pre-formulation and formulation-related activities. She earned her bachelor’s degree in pharmaceutical sciences from India, holds a master’s degree in chemistry, an MBA from the University of Colorado Denver, and Regulatory Affairs Certification (US). Bindu brings a strategic blend of scientific expertise and regulatory strategy, and is dedicated to advancing innovation and excellence in product development at UI Pharmaceuticals.